Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by ASELAGE STEVE

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorNov 29, 2022Buy$1.22409,836500,000483,741Dec 01, 2022, 04:01 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorMay 31, 2022Option Exercise$9.315695,29733,728Jun 02, 2022, 04:43 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorMay 11, 2022Sale$21.922,57556,457146,919May 12, 2022, 08:35 PM
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorDec 10, 2021Buy$2.047,98416,28773,905Dec 13, 2021, 04:02 PM
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorDec 09, 2021Buy$2.152,0164,33465,921Dec 13, 2021, 04:02 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorNov 30, 2021Option Exercise$12.064144,99332,858Dec 02, 2021, 04:15 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 16, 2021Sale$29.3931,800934,602149,494Nov 18, 2021, 04:08 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 05, 2021Option Exercise$21.2320,000424,600171,794Nov 09, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 02, 2021Sale$30.003,500105,00019,500Nov 03, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 01, 2021Sale$29.485,000147,40023,000Nov 03, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorOct 07, 2021Sale$21.24120,0002,548,560249,794Oct 08, 2021, 04:18 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorAug 31, 2021Option Exercise$15.923144,99932,444Sep 02, 2021, 04:28 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorMay 28, 2021Option Exercise$15.776349,99832,130Jun 01, 2021, 04:16 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorApr 16, 2021Option Exercise$21.2320,000424,600198,940Apr 20, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorMar 17, 2021Sale$23.4027,727648,756206,667Mar 19, 2021, 04:05 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorFeb 26, 2021Option Exercise$10.789279,99331,496Mar 02, 2021, 04:47 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorFeb 02, 2021Option Exercise$20.4250,0001,021,000221,667Feb 02, 2021, 09:18 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorDec 15, 2020Sale$26.025,549144,385196,667Dec 16, 2020, 08:55 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorDec 02, 2020Sale$23.437,891184,849202,216Dec 04, 2020, 07:00 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorNov 30, 2020Option Exercise$5.111,9569,99530,569Dec 02, 2020, 04:19 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorNov 05, 2020Sale$21.262,50053,150233,732Nov 06, 2020, 08:56 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorNov 06, 2020Sale$23.0020,625474,375213,107Nov 06, 2020, 08:56 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorAug 31, 2020Option Exercise$4.152,4099,99728,613Sep 02, 2020, 04:36 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorAug 05, 2020Sale$19.682,50049,200236,232Aug 06, 2020, 04:07 PM
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorJul 24, 2020Buy$3.5045,000157,50063,905Jul 28, 2020, 09:02 AM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorJun 25, 2020Sale$20.0010,000200,000238,732Jun 29, 2020, 09:02 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorJun 01, 2020Option Exercise$4.491,1124,99826,204Jun 03, 2020, 04:24 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 12, 2020Sale$17.161,00017,160252,857May 14, 2020, 08:59 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 13, 2020Sale$16.414,06366,674248,794May 14, 2020, 08:59 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 14, 2020Sale$15.093,06246,206245,732May 14, 2020, 08:59 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 05, 2020Sale$15.882,50039,700253,857May 06, 2020, 04:09 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMar 05, 2020Sale$15.364,35966,939256,357Mar 09, 2020, 09:03 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorMar 01, 2020Option Exercise$3.001,6664,99825,092Mar 03, 2020, 12:00 AM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorFeb 05, 2020Sale$16.622,50041,550248,466Feb 07, 2020, 07:38 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorDec 01, 2019Option Exercise$2.851,7544,99923,426Dec 03, 2019, 05:14 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorNov 29, 2019Sale$13.915,00069,552250,966Nov 29, 2019, 09:27 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorNov 18, 2019Buy$1.4515,00021,75021,672Nov 18, 2019, 04:01 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorSep 01, 2019Option Exercise$2.991,6724,9996,672Sep 04, 2019, 04:14 PM
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorJul 03, 2019Buy$3.725,00018,58118,905Jul 05, 2019, 04:08 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorMay 22, 2019Buy$3.573,00010,7105,000May 24, 2019, 04:20 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 14, 2019Sale$17.791,83832,698257,804May 16, 2019, 09:34 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorMay 15, 2019Sale$17.821,83832,753255,966May 16, 2019, 09:34 PM
BCRXBIOCRYST PHARMACEUTICALS INCASELAGE STEVEDirectorMar 12, 2019Buy$8.302,00016,6002,000Mar 14, 2019, 04:18 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerFeb 11, 2019Sale$21.381,06522,770258,707Feb 13, 2019, 08:47 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerFeb 12, 2019Sale$21.501,06522,898257,642Feb 13, 2019, 08:47 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerDec 20, 2018Sale$21.976,188135,958265,960Dec 21, 2018, 08:20 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerDec 21, 2018Sale$21.796,188134,829260,672Dec 21, 2018, 08:20 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerDec 07, 2018Sale$24.0410240251,523Dec 07, 2018, 09:15 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 14, 2018Sale$23.745,550131,735259,433Nov 16, 2018, 07:16 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 15, 2018Sale$24.325,550134,969254,369Nov 16, 2018, 07:16 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerAug 31, 2018Sale$20.3524,000488,400257,883Aug 31, 2018, 07:54 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerMar 07, 2018Option Exercise$6.002781,668221,383Mar 08, 2018, 09:13 PM
ACERAcer Therapeutics Inc.ASELAGE STEVEDirectorDec 14, 2017Buy$12.002,00024,00013,905Dec 18, 2017, 04:01 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerJun 14, 2017Buy$17.855,00089,250245,556Jun 14, 2017, 02:40 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 21, 2016Sale$21.005,000105,000243,756Nov 23, 2016, 04:25 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 22, 2016Sale$21.303,20068,160240,556Nov 23, 2016, 04:25 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 09, 2015Sale$18.7730,000563,100338,756Nov 12, 2015, 01:03 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 10, 2015Sale$18.7230,000561,600308,756Nov 12, 2015, 01:03 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 20, 2014Buy$8.201,30010,660363,056Nov 21, 2014, 06:02 PM
RTRXRetrophin, Inc.ASELAGE STEVEChief Executive OfficerNov 21, 2014Buy$8.508,70073,950371,756Nov 21, 2014, 06:02 PM
RTRXRetrophin, Inc.ASELAGE STEVEDirectorAug 15, 2013Buy$4.505562,502261,756Dec 27, 2013, 07:59 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerJul 02, 2012Option Exercise$28.77190,6905,486,151154,375Jul 05, 2012, 06:30 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerMay 15, 2012Option Exercise$27.9820,000559,67369,030May 17, 2012, 06:10 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerMay 11, 2012Sale$27.5547,6901,313,82880,560May 15, 2012, 08:02 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerApr 30, 2012Option Exercise$19.351,00619,46247,685May 10, 2012, 05:46 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerOct 28, 2011Option Exercise$24.7033,750833,45663,353Oct 31, 2011, 07:17 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerMay 25, 2011Sale$22.1618,354406,81653,155May 26, 2011, 06:55 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerMay 26, 2011Option Exercise$22.1781,0241,795,90184,490May 26, 2011, 06:55 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerMay 03, 2011Sale$22.2420,622458,58541,789May 05, 2011, 01:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerApr 29, 2011Option Exercise$11.641,59718,58331,478May 05, 2011, 01:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerOct 29, 2010Option Exercise$11.642943,42137,881Nov 19, 2010, 03:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerNov 17, 2010Sale$25.129,000226,09561,256Nov 19, 2010, 03:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerNov 18, 2010Sale$20.1362,7501,263,03261,756Nov 19, 2010, 03:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCASELAGE STEVEEVP, Chief Business OfficerSep 08, 2010Option Exercise$16.8770,0001,180,90072,587Sep 09, 2010, 07:18 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe